• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccinati

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Aug 9;15(1):6811.
doi: 10.1038/s41467-024-50997-4. Atypical and non-classical CD45RB[SUP]lo[/SUP] memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19

David G Priest[SUP] 1 [/SUP], Takeshi Ebihara[SUP] 2 3 [/SUP], Janyerkye Tulyeu[SUP] 4 [/SUP], Jonas N Søndergaard[SUP] 4 [/SUP], Shuhei Sakakibara[SUP] 5 6 [/SUP], Fuminori Sugihara[SUP] 7 8 [/SUP], Shunichiro Nakao[SUP] 3 [/SUP], Yuki Togami[SUP] 3 [/SUP], Jumpei Yoshimura[SUP] 3 [/SUP], Hiroshi Ito[SUP] 3 [/SUP], Shinya Onishi[SUP] 3 [/SUP], Arisa Muratsu[SUP] 3 [/SUP], Yumi Mitsuyama[SUP] 3 9 [/SUP], Hiroshi Ogura[SUP] 2 3 [/SUP], Jun Oda[SUP] 2 3 [/SUP], Daisuke Okusaki[SUP] 2 10 11 12 [/SUP], Hisatake Matsumoto[SUP] 13 14 [/SUP], James B Wing[SUP] 15 16 17 [/SUP]



Affiliations
Abstract

Resting memory B cells can be divided into classical or atypical groups, but the heterogenous marker expression on activated memory B cells makes similar classification difficult. Here, by longitudinal analysis of mass cytometry and CITE-seq data from cohorts with COVID-19, bacterial sepsis, or BNT162b2 mRNA vaccine, we observe that resting B cell memory consist of classical CD45RB[SUP]+[/SUP] memory and CD45RB[SUP]lo[/SUP] memory, of which the latter contains of two distinct groups of CD11c[SUP]+[/SUP] atypical and CD23[SUP]+[/SUP] non-classical memory cells. CD45RB levels remain stable in these cells after activation, thereby enabling the tracking of activated B cells and plasmablasts derived from either CD45RB[SUP]+[/SUP] or CD45RB[SUP]lo[/SUP] memory B cells. Moreover, in both COVID-19 patients and mRNA vaccination, CD45RB[SUP]lo[/SUP] B cells formed the majority of SARS-CoV2 specific memory B cells and correlated with serum antibodies, while CD45RB[SUP]+[/SUP] memory are activated by bacterial sepsis. Our results thus identify that stably expressed CD45RB levels can be exploited to trace resting memory B cells and their activated progeny, and suggest that atypical and non-classical CD45RB[SUP]lo[/SUP] memory B cells contribute to SARS-CoV-2 infection and vaccination.


 
Back
Top Bottom